OVERVIEW

Asia Pacific Medical Technology Association (APACMed) Digital Health Symposium 2021 is organized by Asia Pacific Medical Technology Association (APACMed) and will be held on May 04, 2021.

Who Should Attend?
• Leaders from the Pharmaceutical and Medical Technology Industry
• Private and Public Healthcare Providers
• Payers
• Academia
• Technology Companies
• Governments and Policymakers
• Start Ups

Description:
Accelerating Digital Health:
Spotlight on New Care Models
For the past decade, digital health has been heralded as the next disrupter in the delivery of care, but the reality is that, globally, there has been minimal uptake in widespread adoption. While the technology has made great strides to enable digital health, providers, payers, and consumers have been slower to adopt than was anticipated, in part due to slow regulatory approvals and the lack of an adequate reimbursement model. Having said that, the COVID-19 pandemic has been a catalyst in advancing some digital health solutions, specifically in remote patient care.

Building on this momentum and to facilitate the acceleration of digital health, APACMed is organizing the inaugural edition of their Digital Health Symposium.

It aims to bring together international and regional leaders to share learnings around use cases that have succeeded and discuss how Asia can accelerate the implementation of digital health solutions. Speakers will share valuable insights on reimbursement models and challenges to successful remote care management implementations to deliver better patient outcomes.

Join the conversation as the MedTech industry comes together to make concrete recommendations to help shape the implementation of digital health policies that can accelerate access to healthcare with greater agility and quality of care.

Connect with industry leaders, gain new perspectives on the challenges and opportunities of digital health innovations.

Highlights:
• Learn about existing case studies on reimbursement and monetization of remote care management (RCM) models today in Germany and China
• Uncover patient populations which are most likely to benefit from RCM
• Examine the role of RCM against the current pandemic
• Discuss clinical, operational and policy considerations to support a scalable RCM program
• Explore ways to integrate RCM into the continuum of care in Asia